Wallingford, CT, United States of America

Kyle J Eastman

This inventor holds 20 USPTO granted patents and 13 published patent applications and 10 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Achillion Pharmaceuticals, Inc., Bristol-Myers Squibb Compnay, Viiv Healthcare UK (No.5) Limited. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyle J Eastman. Retrieved from https://idiyas.com/inventor/kyle-j-eastman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 13)

% Patents Active = 85.0

EPO Patents = 10 (Patent Applications = 22)

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 72(Granted Patents)

Location History:

Killingsworth, CT (US) (2016)
Killingworth, CT (US) (2012 - 2018)
Wallingford, CT (US) (2018 - 2023)
New Haven, CT (US) (2021 - 2024)

Company Filing History:

10 out of 104

Achillion Pharmaceuticals, Inc.

patents

6 out of 3,742

Bristol-Myers Squibb Compnay

patents

4 out of 45

Viiv Healthcare UK (No.5) Limited

patents

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Pharmaceutical Compounds

Macrocyclic Compounds

Aryl Compounds

Heterocyclic Compounds

Hepatitis C

HIV Replication Inhibitors

Complement Mediated Disorders

Medical Disorders

Substituted Pyridines

Imidazo Derivatives

Fused Furans

Cyano Compounds

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12479856 - Pharmaceutical compounds for the treatment of complement mediated disorders (2025-11-25),

2. 12297205 - Macrocyclic compounds for treatment of medical disorders (2025-05-13),

3. 12162860 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2024-12-10),

4. 12006307 - Pharmaceutical compounds for treatment of medical disorders (2024-06-11),

5. 11814391 - Macrocyclic compounds for the treatment of medical disorders (2023-11-14),

6. 11718626 - Macrocyclic compounds for treatment of medical disorders (2023-08-08),

7. 11708351 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2023-07-25),

8. 11447465 - Pharmaceutical compounds for treatment of medical disorders (2022-09-20),

9. 11084800 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2021-08-10),

10. 11053253 - Macrocyclic compounds for treatment of medical disorders (2021-07-06),

11. 10351546 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-07-16),

12. 10214534 - Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C (2019-02-26),

13. 10189816 - Substituted pyridines as inhibitors of human immunodeficiency virus replication (2019-01-29),

14. 10065953 - Imidazo[1,2-A]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication (2018-09-04),

15. 9957278 - Furopyridine compounds for the treatment of hepatitis C (2018-05-01),

Title: The Innovative Journey of Kyle J Eastman

Introduction: Kyle J Eastman is a pioneering inventor based in New Haven, CT, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kyle J Eastman holds several patents in the realm of artificial intelligence and renewable energy technologies, showcasing her commitment to creating a sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Kyle J Eastman has led numerous projects that have revolutionized the way we approach complex challenges in various industries.

Collaborations: Throughout her career, Kyle J Eastman has collaborated with leading research institutions and tech companies to bring her ideas to life, fostering a culture of innovation and creativity.

Conclusion: Kyle J Eastman's dedication to pushing the boundaries of what is possible through her inventive spirit continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.